Early Human Data Suggests Psychedelics May Help Reduce Inflammation
Early human findings suggest psychedelics may have potential against inflammation, with possible implications for neurodegenerative diseases.
AI-written summary · The Chestnut Post · · How we use AI
Researchers are publishing some of the first human data suggesting psychedelics could have potential to reduce inflammation, according to NPR.
Laboratory studies have found that psychedelics such as psilocybin can reduce inflammation and may offer protection against a variety of illnesses.
The emerging human findings point to possible applications for patients with neurodegenerative conditions, including Parkinson’s disease. The results suggest potential rather than an established treatment benefit.
Originally reported by NPR. Read the full story at NPR
